Viewing StudyNCT00026416



Ignite Creation Date: 2024-05-05 @ 11:24 AM
Last Modification Date: 2024-10-26 @ 9:06 AM
Study NCT ID: NCT00026416
Status: UNKNOWN
Last Update Posted: 2014-01-06
First Post: 2001-11-09

Brief Title: Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma
Sponsor: Herbert Irving Comprehensive Cancer Center
Organization: National Cancer Institute NCI

Organization Data

Organization: National Cancer Institute NCI
Class: NIH
Study ID: CDR0000069028
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Herbert Irving Comprehensive Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH